Lecture 9 - Clinical Genetics Flashcards

1
Q

What is the pattern of inheritance of CF?

A

Autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Which ethnicity is most affected by CF?

A

Caucasian, mostly northern european

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the incidence of CF?

A

1 in 2500-3000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Why is CF important?

A

Most common single genetic condition causing premature death in children of northern European descent

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is a possible selective advantage of heterozygotes for CF?

A

Postulated protection from cholera, typhus, asthma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe the interaction between Salmonella and CF

A

The CF bacterium uses CFTR protein to gain entry to gut epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

In which ethnicities is CF prevalence very low?

A

Japanese population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is often seen in CF pedigrees?

A

Absence of prior family history
‘suddenly appears’
This is because it is autosomal recessive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe the genotype-phenotype correlations in CF

A

Not as strong as one might think

• Pancreatic insufficiency in Class I-III mutations has strong correlation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are class I-III mutations usually correlated with?

A

• Pancreatic insufficiency; very strong correlation

Also, to a certain degree,
• More severe lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are class IV-V mutations usually correlated with?

A
  • Pancreatic Sufficiency (PS)

* Milder lung disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the interaction of the R117H mutation and other genotypes

A

Depending on the n° of T’s in cis to this mutation, the clinical penetrance is variable
R117H + 5T: will likely have disease causing mutation
R117H + 7T: unlikely to be a disease causing mutation
R117H + 9T: highly unlikely to act as a disease causing mutation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe Steven’s genotype and phenotype

A

Homozygous F508del

Less severe phenotype than Sean

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the best way to do studies that want to determine environmental and genetic modifiers?

A

Monozygotic twin studies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the effects of genes and environment on lung function in CF?

A

50-50 genes and environment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is meconium ileus?

To what degree is it affected by genes and environment

A
  • Blockage in ileum of babies in utero by sticky, black faeces
  • almost completely determined by genes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Why is it important to identify genetic modifiers of CF?

A

• new targets for therapies
• understanding of disease variability
etc.

18
Q

How does one identify genetic modifiers of CF?

A
  • Linkage studies: track markers with specific phenotypes
  • Candidate gene association
  • Genome wide association studies
19
Q

What are GWAS?

What information can they deliver?

A

Genome wide association studies

  1. Sequence entire genome
  2. Look for:
    • Disease associated SNPs
    • Nondisease associated SNPs
20
Q

What are limitations of GWAS?

A

Need a large sample size

21
Q

What is EDNRA?

A

Encodes Endothelin receptor - A

Normally:

  1. Endothelin binds EDNRA
  2. Induction of vasoconstriction and bronchoconstriction

If there is a variation in this receptor, they may be decreased constriction in the lungs; thus, less severe lung disease.

• A genetic modifier of lung disease in CF

22
Q

What is MBL2?

A

Encodes mannose binding lectin
• role in innate immunity (in lungs)
• important for P. aeruginosa immunity
• genetic modifier of lung disease in CF

23
Q

What is TGFB1?

A

Gene encoding TGF-B
• genetic modifier of lung disease in CF
• role in regulating inflammation and tissue remodelling

24
Q

What are some genetic modifiers of lung disease in CF?

A
  • TGFB1
  • MBL2
  • EDNRA
25
Q

What is an example of a genetic modifier of intestinal obstruction in CF?

A

MSRA

26
Q

What is MSRA?

A

Encodes methionine sulphide reductase
• role in modifying intestinal enzymes
• variants may alter digestion

27
Q

What is TCF7L2?

A
  • encodes transcription factor 7-like 2
  • genetic modifier of Diabetes in CF
  • role in proliferation of B cells in pancreatic islets
28
Q

What are some environmental modifiers of CF?

A
  • being female: diet and therapy adherence
  • lower socio-economic
  • tobacco smoke exposure
  • infectious exposure
  • disease self-management
29
Q

What are the various types of screening carried out for CF?

A
  • Newborn screening
  • Cascade testing
  • Population carrier testing
30
Q

Describe the various stages of newborn screening

Why is this testing carried out?

A

This is carried out to identify babies at risk of CF

  1. IRT test in heel prick test onto Guthrie card
    • Elevated IRT → further testing
  2. DNA testing; 12 mutation panel
    • two mutations → baby has CF
    • heterozygous for mutation → need further testing
    • no mutations → baby doesn’t have CF
  3. Sweat test
    • elevated Cl- and Na+ in sweat → baby has CF
    • equivocal result → child may / may not have CF
    • normal sweat → normal CF, but baby is a carrier
31
Q

Describe cascade testing

A
  • Identification of carriers in wider family of the affected child
  • Only 12% opt-in
32
Q

Describe population carrier screening

A
  • Identification of carriers in the general population
  • Screening of pregnant couples etc.
  • Very expensive
  • Ethical issues
  • Overseas companies offering this service also
33
Q

Why is a sweat test carried out?

A
  • In heterozygous newborns

* determines whether the baby requires treatment

34
Q

What is PGD?

A

Pre-implantation genetic diagnosis
• During IVF
• Cells removed; unaffected embryos are implanted

35
Q

Describe candidate gene association

A

Choose a gene as a candidate

  • looks at the gene in two people

* compare the results

36
Q

What is IRT?

A

Immunoreactive Trypsinogen

37
Q

What happens if there is an ‘equivocal result’ from the sweat test?

A

The baby may or may not have CF

Further monitoring required

38
Q

Which class of mutation is F508del?

A

Class II

39
Q

Which parameter is being tested on the Guthrie card?

A

IRT levels in baby’s serum

40
Q

Compare the implication of the various results of the sweat test

A

> 60 mmol/L → child has CF

30-60 mmol/L → equivocal result

<30 mmol /M → child does not have disease but it a carrier